Experiments are described using rats with two kinds of brain damage and consequent cognitive deficit (in the Morris water maze, three-door runway, and radial maze): 1) ischemic damage to the CA1 hippocampal cell field after four-vessel occlusion (4VO), and 2) damage to the forebrain cholinergic projection system by local injection of excitotoxins to the nuclei of origin or prolonged ethanol administration. Cell suspension grafts derived from primary fetal brain tissue display a stringent requirement for homotypical cell replace ment in the 4VO model: cells from the embryonic day (E)18-19 CA1 hippocampal subfield, but not from CA3 or dentate gyrus or from El6 basal forebrain (cholinergic rich) led to recovery of cognitive function. After damage to the cholinergic system, conversely, recovery of function was seen with cell suspension grafts from E16 basal forebrain or cholinergic-rich E14 ventral mesencephalon, but not with implants of hippocampal tissue. These two models therefore provided a test of multifunctionality for a clonal line of conditionally immortalized neural stem cells, MHP36, derived from the E14 "immortomouse" hippocampal anlage. Implanted above the damaged CA1 cell field in 4VO-treated adult rats, these cells (multipotential in vitro) migrated to the damaged area, reconstituted the gross morphology of the CA1 pyramidal layer, took up both neuronal and glial phenotypes, and gave rise to cognitive recovery. Similar recovery of function and restoration of species-typical morphology was observed when MHP36 cells were implanted into marmosets with excitotoxic CA1 damage. MHP36 implants led to recovery of cognitive function also in two experi ments with rats with excitotoxic damage to the cholinergic system damage, either unilaterally in the nucleus basalis or bilaterally in both the nucleus basalis and the medial septal area. Thus, MHP36 cells are both multipotent (able to take up multiple cellular phenotypes) and multifunctional (able to repair diverse types of brain damage).
INTRODUCTION
Progress in the clinical application of transplants of primary tissue directly derived from the fetal human brain into the damaged adult brain has been consider able, especially in patients with Parkinson's disease (33) . It is generally agreed, however, that the wider clin ical application of neural transplantation requires the de velopment of alternative sources of cells, which can be maintained in vitro until needed for surgery and which will obviate the substantial ethical and practical difficul ties attendant upon the use of freshly derived human fe tal tissue (18) . Like others (34, 35) we see the most promising avenue for the generation of such alternatives as lying in the development of neural stem or progenitor cell lines (18) . In our own experiments, we have focused on the use of cell lines derived from a transgenic mouse (28) , now known familiarly as the "immortomouse," which harbors a temperature-sensitive (ts) mutated allele (A58) of the SV40 large-T antigen (T-ag) under the con trol of the interferon-inducible H-2K b promoter. This on cogene is stably expressed in cells cultured at tempera tures below mammalian body temperature (e.g., 33°C) but is downregulated at normal body-or brain-temp erature (37-39°C) . Cells into which the oncogene has been introduced may therefore be maintained and ex panded in vitro at the permissive temperature of 33°C; upon implantation into a host brain, however, they cease dividing and enter the pathway to differentiation. Other oncogenes that have been used in a similar way include different isoforms of myc, neu, and p53 (34) . Impor tantly, neither in vitro nor in vivo (after transplantation into a host brain) has there been any evidence so far of transformation of cells treated in this way. In this article we describe our results with one such cell line (MHP36), derived from the immortomouse hippocampal anlage on embryonic (E) day 14 (i.e., just prior to the time at which these cells migrate away from the ventricular zone to form the hippocampus) (43) .
Before coming to the experiments using this cell line, however, we first briefly review results obtained in ear lier experiments in which we transplanted primary fetal rat brain tissue into the damaged adult rat brain. It is only in the light of these experiments with primary fetal tissue grafts that one can fully appreciate the signifi cance of the effects obtained subsequently with the MHP36 cell line.
EXPERIMENTS WITH PRIMARY FETAL TISSUE
In our earlier experiments we studied rats that had sustained two very different types of damage. The first consists in a relatively specific loss of pyramidal cells in the CA1 field of the hippocampus and in the hilus of the dentate gyrus after four-vessel occlusion (4VO) (i.e., permanent coagulation of the vertebral arteries followed next day by temporary ligation of the carotid arteries), simulating damage that often occurs in humans follow ing cerebral ischemia due to heart attack or coronary artery occlusion (46, 48) with consequent profound and enduring cognitive, and especially memory, impairments [(29,48) ; reviewed in (26) (44) ]. We used standard methods [ (7) ; and see the original experimental reports cited below] for dissecting primary tissue from the rat brain and pre paring cell suspensions for subsequent implantation into these two models of adult brain damage. The tissue we used was derived from either the hippocampus (El 8-
19)
, dentate gyrus [EI8-19 or postnatal (P) day 1-2], basal forebrain (El6), or ventral mesencephalon (El4).
The latter two sources of tissue are rich in cholinergic cells. With cholinergic-rich grafts, we aimed to restore cholinergic function in animals with damage to choliner gic projections and, with hippocampal grafts, to repair damage to hippocampal circuits, aims that were largely accomplished.
The experiments (25, 36) in which we injected sus pensions of primary fetal cells into the damaged rat hip pocampus used two measures of spatial learning and memory, the Morris water maze and the three-door run way, to assess cognitive deficit and recovery. These ex periments demonstrated that, for recovery of cognitive function to be observed, there is a rather stringent re quirement that the implanted cells be homotypic to the CA1 pyramidal cells that constitute the primary popula tion damaged by 4VO. Cell suspensions derived from nonhippocampal, cholinergic-rich tissue (El6 basal fore brain), from El8-19 or PI-2 dentate gyrus, or from the El8-19 CA3 cell field all failed to ameliorate the cogni tive deficits caused by 4VO. All of these cell suspen sions except those derived from the PI-2 dentate gyrus produced substantial surviving grafts, as observed in postmortem histology (for an example, see cell field gave rise to nearly total recovery of cognitive function over a period lasting from 3 up to 9 months after implantation, the maximum time for which the ani mals were followed up. The difference between the ef fects obtained with grafts derived from the CA1 and CA3 cell fields is particularly striking. In both cases the postmortem material showed large and healthy surviving grafts located, somewhat ectopically, in the same re gions (targeted by the injections), usually in white mat ter just above the site of damage to the host CA1 pyram idal cell layer, and containing mature pyramidal cells of appropriate morphology. Both CA1 and CA3 pyramidal cells are excitatory and glutamatergic. Evidently, there fore, recovery of function after transplantation in the 4VO-damaged hippocampus requires more than just the presence of cells that secrete the right neurotransmitter in the right general location.
The experiments (1, 2, 5, 6, (21) (22) (23) in which we at tempted to reverse the cognitive deficits caused by dam age to the forebrain cholinergic projection system dif fered in an important respect from those using the 4VO model, in that the cell suspension grafts were placed, not into the primary area of damage (the hippocampus in animals subjected to 4VO), but into the terminal regions suffering from cholinergic deafferentation (i.e, the neo cortex, target for the projection from the nucleus basalis, and hippocampus, target for the projection from the me dial septal area). The logic behind this difference in approach (which is typical of the field) is that the hippo campus represents an example of point-to-point cir cuitry, whereas the forebrain cholinergic projections constitute a diffuse modulatory system with widespread ramifications [see (45) for an extended discussion of this contrast]. In this respect, the cholinergic system resem bles the ascending dopaminergic projections, such as the nigrostriatal pathway, which degenerates in Parkinson's disease. Here, too, in both animal experiments and clini cal application, the transplanted cells are placed in the terminal region, the striatum, denervated by degenera tion in the nigrostriatal pathway (3, 8, 10, 33) . Despite this ectopic location, dopaminergic-rich grafts are able to re-verse the behavioral deficits seen after damage to the nigrostriatal system, a fact (along with many others) consistent with the possibility that such grafts act by se creting the transmitter, or some other substance, so that it diffuses into the surrounding tissue, rather than by conventional point-to-point synaptic transmission (though there is, nonetheless, evidence of synaptic contact and transmission). This quasi-pharmacological mode of ac tion is equally likely to apply in the case of the choliner gic system, a hypothesis that, as we shall see, our data support. But it does not seem likely to apply CAI pyra midal neurons, which communicate to a small set of pre cisely defined and nearby targets (principally in the subiculum); nor, as noted above, do the results of our grafting experiments in the 4VO model suggest such a mode of action.
The major conclusions to which these experiments led apply equally well whether the damage to the fore brain cholinergic projection system is bilateral (5, 6, (22) (23) (24) or unilateral (1,2); whether it affects just the nucleus basalis (1, 2) or this plus the septal area (5, 6, 22, 23) ; and whether the damage is due to local administration of an excitotoxin-ibotenate (22, 23) or a-amino-3-hydroxy-4-isoxazole propionic acid (S-AMPA) (1,2)-or to pro longed exposure to alcohol in the drinking water (5, 6, 24) .
We shall therefore make little distinction here between these types of damage. The resulting cognitive deficits were measured in Jarrard's version of the radial-arm maze (27) , measuring spatial and nonspatial reference and working memory, and the Morris water maze. Over all, the pattern of results was clear: grafts of El 8-19 hippocampal tissue were always without effect; clear re covery of function was seen, in contrast, when cholinergic-rich grafts, whether derived from El6 basal fore brain or E14 ventral mesencephalon (24) , were placed in either the hippocampus or the septal area or both these regions.
In rats with damage to both the nucleus basalis and the medial septal area, cognitive function was restored to an equal extent, and indeed almost completely, by cholinergic-rich grafts into either the cortex or the hip pocampus (22) . In rats exposed to 6 months of alcohol consumption, with pronounced falls in cholinergic mark ers in both cortex and hippocampus, cholinergic-rich grafts into either of these regions produced partial recov ery of function, and grafts into both regions had additive effects (5, 6) . Both these patterns of improvement, to gether with the general location of the grafts at sites distal from the region of initial damage, suggest a dif fuse, quasi-pharmacological mode of action similar to one of the mechanisms that has been proposed to under lie the capacity of dopaminergic-rich grafts to restore function after nigrostriatal damage (see above). The fact that cholinergic-rich grafts are equally effective in re storing cognitive function whether they are derived from the fetal basal forebrain homologous to the region dam aged in the adult brain or from the fetal ventral mesen cephalon (containing the cholinergic pedunculopontine nucleus) also speaks for a diffuse mode of action of the grafts, the specific type of cell that secretes acetylcho line being of little importance. The likely importance of the specifically cholinergic nature of the implanted cells received support from a series of drug challenges, both systemic with behavioral measurement (23, 24) and iontophoretic with electrophysiological observations (1), and from evidence in all of these studies that those grafts that restored cognitive function also restored cholinergic biochemical and/or histochemical markers in the dener vated terminal regions. It should be noted, however, that the requirement for specifically cholinergic replacement is seriously challenged by the finding reported by Brad bury et al. (9) that, when cells derived from El6 basal forebrain are separated prior to implantation into astro cytic and neuronal populations, the former (but not the latter) give rise to cognitive recovery, whereas the latter (but not the former) restore levels of choline acetyltrans ferase in the denervated terminal regions.
In summary, these experiments indicate a double dis sociation that will be important for the logic we pursue here. When cell suspensions derived from primary fetal tissue are used in grafting experiments, those taken from the fetal hippocampus are unable to restore cognitive function after damage to the forebrain cholinergic pro jection system, but (provided they contain cells from the CAI subfield) they do restore cognitive function upon implantation into a brain with 4VO-induced damage in the CAI region. Conversely, cells derived from the cho linergic-rich fetal basal forebrain are ineffective in the 4VO model, but restore cognitive function after implan tation into a brain with damage to the forebrain choliner gic projection system. This difference cannot be due to the site at which the cells are implanted because, in some of the experiments, identical sites (just above the alveus covering the dorsal hippocampus) were used for implantation either of basal forebrain or of hippocampal cells into animals with either damage to CAI or to the forebrain cholinergic projection system [compare (6, 22, 23) with (25, 36) ]. Presumably, therefore, the specificity of the effects observed reflects an interaction between the type of fetal cells implanted, on the one hand, and that of the damage these cells encounter, on the other.
In general, with the exception of the findings reported by Bradbury et al. (9) noted in the preceding paragraph, the nature of this interaction suggests a requirement that the cells implanted be homotypic with those that were previously damaged (i.e., cholinergic for cholinergic system damage, CAI cells for CAI damage). This con clusion is particularly compelling in relation to the stud-ies of 4VO-induced damage in CA1: our data indicate that CA1 pyramidal cell loss can be repaired by fetal CA1 cells but not by the very similar CA3 cell popula tion.
NEURAL STEM CELLS
Stem cells in the central nervous system have the po tential to develop into neurons, astrocytes, and oligoden drocytes, as well as to renew themselves as stem cells (35) . These properties jointly define the concept of is to generate immortalized cell lines that combine two features: first, they should be capable of being main tained in vitro indefinitely, so that they are readily avail able for implantation into a host brain; second, they should be able to repair the damage present in the host brain. Because the range of both cell types and brain regions affected by brain disease or damage is large, the cell lines must correspondingly be applicable to a diver sity of tasks of repair. Clearly, this might require genera tion of many different types of cell line. However, the multipotentiality of neural stem cells raises the possibil ity that a relatively small number of cell lines would be capable of repairing many different kinds of brain dam age. We devote the rest of this article to an exploration of this possibility, including a brief account of experi ments from our own laboratory that suggest its feasi bility.
A number of rodent neuroepithelial stem or progeni tor cell populations have been immortalized, mostly with the ts A58 SV40 T-ag oncogene, which we too have used, and the resulting cell lines explored for their potential in populating and repairing the brain (4, 13, 39, 42, 46, (50) (51) (52) (53) implanted. In these experiments transplantation was made into the postnatal brain. Implantation of geneti cally labeled primary striatal cells into the ventricles of the embryonic mouse brain, by injection via the uterine wall, further showed that these cells migrate to several different sites in the host brain and take up different characteristics depending upon their eventual home.
Thus, the same population of striatal precursors mi grated out to give rise to cortical, thalamic, and tectal neurons (11, 12) .
The ability of neural stem cells to migrate to multiple brain regions and to take up multiple phenotypes en courages hopes that these properties can be utilized for repair of the damaged brain. However, in the experi ments reviewed so far, the sites in the developing brain at which the implanted cells differentiated into their fi nal phenotypes were ones at which neurogenesis was current at the time, and the observed migration of the implanted cells formed part of current migratory streams from the ventricles to the still forming brain mantle. The environmental signals that drive these responses in the implanted cells are presumably signals that occur as part of the normal process of development. It might be doubted, therefore, that such signals would be still gen erated in the adult brain, or that they would be able to direct migration and/or neurogenesis in such a manner as to provide a means of repairing damage to the adult brain. However, as we shall see, our evidence is that processes of this kind can indeed occur.
Previous experiments, as reviewed by Martinez-Ser rano and Bjorklund (36) , have shown that immortalized neural stem cells provide a promising avenue for future human neurosurgery. A favored approach in these ex periments has been, prior to implantation, to genetically engineer the cell line so that it can deliver to the brain a desired therapeutic substance (e.g., tyrosine hydroxy lase in the case of damage to the nigrostriatal pathway).
Our own approach, however, has been different. Rather than determine in advance that a particular type of cell producing a particular substance is required for repair of the damaged brain, we have asked whether the damaged brain might itself produce signals, analogous to those that direct site-specific differentiation in the normal de-veloping brain, with the capacity to bias the differentia tion of the implanted stem cells to adopt a phenotype appropriate to the damage. We have not, however, di rectly sought such signals. We instead adopted a func tional approach: we suppose that any such signal-di rected repair of the damaged brain should manifest itself as recovery of the behavioral performance otherwise im paired by the damage. The stringent requirement, as re viewed above, when using primary fetal cell suspensions as grafts, for restoration of cognitive function in the 4VO model that these cells be taken specifically from the fetal CAI region homotypic to the main region of damage in the host brain made this model an ideal test bed in which to pose the following question: would con ditionally immortalized neural stem cells respond to sig nals of damage in the adult brain by taking up a pheno type appropriate to the nature of the damage and so give rise to recovery of function? (37) , these were all shown to be conditionally immortal. At 2-6 days in vitro under permissive culture conditions they showed 1-2 xlO 3fold proliferation in serum-free media without added FGF2, with a rapid reduction in numbers when tempera ture was raised to 39°C in the absence of interferon. One of these "Maudsley Hippocampal" (MHP) lines, MHP36, was extensively characterized further and used in trans plantation studies (43) . In culture this cell line was highly responsive to FGF2, substantially increasing in number in both permissive and nonpermissive condi tions.
EXPERIMENTS USING MHP CELL LINES: HIPPOCAMPAL DAMAGE
In permissive culture the MHP36 line ubiquitously expressed immunoreactivity to the SV40 T antigen and to the neuroepithelial stem cell marker, nestin (32); la beling with bromodeoxyuridine (BrdU) confirmed the presence of dividing cells; and no cells were observed that were positive for either the neuronal marker, PGP 9.5 (55), or the astroglial marker, glial fibrillary acidic protein (GFAP). Following switch to nonpermissive conditions in serum-free medium, and only in the pres ence of one of retinoic acid, forskolin, or dibutyril cAMP, the cultures could be maintained for at least a further 14 days in vitro. Both SV40 T-antigen and nestin expression were strongly downregulated, BrdU staining was greatly reduced, and cells positive for either PGP 9.5 or GFAP could now be detected. Many of the PGP 9.5-positive cells had long neuritic processes (see Fig.  2C ). Depending upon the conditions of differentiation (e.g., with retinoic acid or forskolin), the proportions of cells showing neuronal or glial markers respectively var ied somewhat, but never reached 100% neuronal or glial expression. Expression of oligodendrocyte markers has also been observed in these experiments.
These observations in vitro indicate that the MHP36 line is a multipotent neural stem cell line and a suitable tool, therefore, with which to test our primary hypothe sis. Accordingly, we implanted this cell line into rats which, 2-3 weeks previously, had been subjected to 15min 4VO, with the expected consequent damage to the hippocampal CAI pyramidal cell layer [for details, see Sinden et al. (43) ]. We employed the same stereotaxic coordinates for injection as in the earlier experiments using primary fetal grafts (i.e., bilaterally just above the alveus directly over the region of maximal CAI cell loss, not into the CAI cell layer itself). The same num ber of cells was injected as in the experiment using pri mary fetal grafts (i.e., a total of 100,000 cells per rat). (43) . Histological analysis post mortem, using either X-gal histochemistry or an anti-Pgal antibody to detect the lac-Z reporter gene, revealed a remarkable capacity of the injected cells to migrate to, and partially reconstitute the gross morphology of, the damaged host CAI cell layer. The resulting appearance of the brain (Fig. 1) , with in particular a normal laminar pattern in the CAI cell field, is quite different from that seen with primary fetal grafts. Double labeling for PGP 9.5 or a second neuronal marker, NeuN ( Fig. 2A, B) , or GFAP showed, further, that some of the MHP36 cells had acquired a neuronal and others an astroglial pheno type (43) . In a majority of cells expressing the lacZ gene, however, we failed to detect either marker, al though this does not preclude the possibility that these unidentified cells express markers for other cell types (e.g., oligodendrocytes). Notably, a number of labeled implanted cells are clearly observed in the hilus of the dentate gyrus, which is the second main area of damage seen in the hippocampal formation after 4VO. The MHP36 PGP 9.5-positive cells observed in the CA1 layer were clearly pyramidal in morphology. In some animals, cells were inadvertently injected into the dentate gyrus; in these, a few implanted cells were observed with the appearance of granule cells. It is likely that this outcome was dependent upon the damage caused in the dentate gyrus by the needle inser tion, because we did not otherwise see cells take up granular morphology or a location in the dentate gyrus.
Behavioral testing commenced 3 or 5 months (in two separate experiments) after the implants of MHP36 cells. In both cases, essentially complete recovery of function (compared to intact controls) was observed in the Morris water maze

In further experiments we have followed the time course of migration of the implanted cells towards the damaged CAI cell region. In the first week after injec-
These experiments appear to warrant a number of conclusions. First, confirming earlier work (34, 35) , neu ral stem cells are multipotent both in vitro and in vivo.
Second, such cells may be rendered conditionally im mortal and maintained through multiple passages in vitro (currently, the MHP36 line is at passage 60), but still retain their capacity to differentiate upon transition to nonpermissive conditions favorable for differentia tion.
Third, also confirming earlier work, the tsA58 SV40 Fourth, upon implantation into a damaged adult brain, MHP36 cells preferentially migrate towards a re gion of damage (see Fig. 3 for an example) and take up both a location and a morphology that are appropriate to the lost host cell type. This result contrasts with previous reports [reviewed in (34) ], in which immortalized cell lines have tended to avoid areas of damage in the host brain, although similar results have been reported by Snyder et al. (47) . It is not at present clear why the MHP36 cell line targets damage in this way, whereas other cell lines have not generally shown this property.
Fifth, the implanted MHP36 cells gave rise to recov ery of cognitive function that was essentially complete, and as good as that seen after transplantation of primary fetal cell suspensions. The Sinden et al. (45) study was the first demonstration that conditionally immortalized neural stem cells can give rise, after implantation into the damaged adult brain, directly to behavioral recovery, rather than by acting as carriers for specific genes (e.g., after transfection with tyrosine hydroxylase) (34) . Be cause the model we employed-4VO-induced hippo campal damage-is one in which there is a stringent requirement, when primary fetal tissue is used as the source of implanted material, for homotypic cell re placement [(25,36) ; see above], this result strongly im plies that the MHP36 cells responded to signals indica tive of CAI cell loss by taking up a phenotype capable of replacing the lost host cells with ones sufficiently like them to be able to restore function.
As a possible objection to the last of these conclu- Figure 3 . Confocal image showing that mouse MHP36 cells (labeled with fluorescent micro spheres), injected (large arrow) into rat brain, migrate to ischemia-induced damaged CAI in the hippocampus (small arrows). Prelabeled mouse MHP36 cells were injected into layers III-VI of the rat cortex 2 weeks after cerebral ischemia was induced by the four-vessel occlusion method. The fate of the transplanted cells was then monitored 12 weeks posttransplantation. sions it might be argued that the implanted cells that restored cognitive function did so because they were al ready fated to become CAI pyramidal cells. This possi bility can be discounted on several grounds. 1) The MHP36 cells do not appear to be unduly restricted in their lineage, because both neuronal and glial pheno types emerge from the same clone. 2) Even within the neuronal lineage, we have observed granule cell mor phology in the case of MHP36 cells injected into the dentate gyrus. 3) Cell lineage data suggest that neuronal precursor cells of the embryonic hippocampus are not confined to generate neurons destined for a single hippo campal field (20) . Rather, each precursor cell may con tribute neurons to multiple fields. It is unlikely, there fore, that individual MHP lines carry a specific CAI or CA3 identity, because the current evidence suggests that the embryonic precursor cells from which they are de rived themselves carry no such identity.
Given the evidence (reviewed above) that, in the de veloping brain, differentiation of implanted stem cells is influenced by ongoing neurogenesis, we must also con sider the possibility that differentiation of the implanted MHP cell lines was influenced by continuing neurogen esis in the host brain. However, the cells that, in the hippocampal formation, undergo continuing neurogen esis in the adult rat brain are not the pyramidal cells of the hippocampus proper but the granule cells of the den tate gyrus (30) . Thus, if MHP36 cells implanted into the adult brain were simply to take part in an ongoing pro cess of neurogenesis, we should have observed them taking up a granule cell phenotype in the dentate gyrus.
But, as noted above, this occurred only when, inadver tently, we damaged the dentate gyrus by inserting a nee dle there; we did not observe the implanted cells in the undamaged dentate.
The experiments considered so far have all been con ducted with rodents. Can the results be generalized to humans? As a first step towards answering this question, we have commenced a series of studies with a newworld monkey, the common marmoset. In these experi ments we have adopted procedures developed by Ridley et al. (40, 41) , in which the CAI field is lesioned by local injection of the excitotoxin, Af-methyl-D-aspartate (NMDA), and learning and memory is assessed in the Wisconsin General Test Apparatus. After this lesion the monkey has no difficulty in retaining simple discrimina tions learned prior to surgery, nor in learning new sim ple discriminations, but has profound difficulty in either retaining or learning new conditional discriminations.
(In a simple discrimination, the animal must choose, e.g., one object out of two to obtain a reward; there is an invariant association between the positive object and the reward. In a conditional discrimination, the animal, e.g., is faced with two identical objects, and for some pairs the rule is to respond to the one on the left while for others it is to respond to the one on the right; here, then, the rule is relational.) This pattern of impairment bears many similarities to the cognitive deficits seen in humans after hippocampal damage (15) .
Ridley et al. (41) showed that it is possible to amelio rate these effects of CAI damage by implantation of sus pensions of primary cells taken from the E95 marmoset hippocampal CAI field, a finding we have confirmed.
Given these results with fetal grafts, we were in a posi tion to determine whether similar effects might be ob tained with conditionally immortalized neural stem cells.
As far as we are aware, there are as yet no cell lines of this kind of primate origin. However, there are previous examples in which grafted neural tissue has succeeded in producing recovery of function despite wide species differences (53, 54) , and indeed such xenografts (por cine) are already in use as an experimental treatment of patients with Parkinson's disease (14) . We (49a) there fore employed the same mouse-derived MHP36 cells as in the experiments on the 4VO rat. Unlike the experi ments with rats, in which immunosuppression was ap plied to the hosts for only 2 weeks from the time of transplantation, the marmosets were administered cyclo sporine A in Cremaphor EL at a dose of 10 mg/kg IM 5 times a week until sacrifice. The experiment was iden tical to the one using marmoset fetal grafts, but using the MHP36 cell line (100,000 cells at a density of 25,000 cells per ul injected at each of 5 sites bilater ally-10 sites in all-along the CAI cell field, i.e., a total of 1 million cells per marmoset, comparable to the number of primary fetal cells used per marmoset). The results obtained with the two types of transplanted tissue were very similar: like the fetal grafts, the MHP36 cells restored the animal's capacity both to retrieve previously learned conditional discriminations and to acquire new conditional tasks (Fig. 4) . In the marmoset, as in the rat experiments, the MHP36 cells, identified by p-gal immunohistochemistry, reconstructed the damaged CAI field in a species-specific manner (Fig. 5 ). In the rat material, the cells were densely aligned in the CAI field, whereas in the marmosets they were evenly distributed across the broader, more sparsely populated field, char acteristic of the primate brain.
EXPERIMENTS USING MHP CELL LINES: DAMAGE TO THE CHOLINERGIC SYSTEM
The experiments described in the preceding section demonstrate that, in both rats and marmosets, implants of the mouse-derived conditionally immortal MHP36 cell line have the following properties: 1) they are able to restore cognitive function impaired by prior damage primarily to the CAI cell field of the hippocampus; 2) these cells migrate, disperse into the damaged region of indistinguishable from the intact controls, and even nu merically barely distinguishable from them. The stability of the graft effects is also impressive. In the nucleus basalis experiment, they are as marked after a month's break in testing as before the break; and in the basalis plus septal experiment function was clearly restored as long as 6 months after implantation. Most importantly, from the point of view of future clinical application, in the latter experiment the grafts were effective even though they were not implanted until 6 months after the lesion. This observation raises hopes that similar cell lines will be capable of exerting therapeutic effect even if they are used to treat chronically disabled patients at times long after the initial insult. As noted above, the MHP36 cell line is derived from tissue (taken from E14 mouse hippocampal anlage) that is destined to form the various cell types that inhabit the adult hippocampus. Yet the results displayed in Figures  6 and 7 show that grafts of these cells are capable of restoring cognitive function impaired by damage that not only does not include hippocampal cells, but which our previous experiments with primary fetal grafts (summa rized above) had shown cannot be repaired by tissue that has already differentiated (by El8-19 in the rat) into hippocampal cells. Clearly, therefore, the restorative ca pacity of the MHP36 cell line is not limited to damage to hippocampal cells as such. If we had only the results of the basalis plus septal experiment to go by, there would still be the possibility that MHP36 cells are none theless effective only in conditions in which the function However, in the nucleus basalis experiment, the cholin ergic projection to the hippocampus was intact, and the cells were not implanted into the hippocampus. Thus, there need be no involvement of the hippocampus in any way for MHP36 cells to give rise to recovery of function.
Given the many differences between the two models of damage upon which this article has concentrated [e.g., the fact that CAl damage interrupts a point-to-point syn aptic pathway whereas nucleus basalis and septal dam age remove diffuse modulatory projections (45) ; or the fact that, with CAl damage, effective grafts were im planted into the damaged region itself whereas, with damage to the cholinergic system, they were placed into the denervated terminal regions], it seems likely that the range of application of grafts of MHP36 and other simi lar cell lines will in fact turn out to be even wider than these two models alone suggest. We anticipate that his tological investigation (currently under way) of the re sults of the two experiments on the cholinergic system will throw some light upon the range of such possibili ties.
CONCLUSIONS
Taken together, the experiments discussed in this arti cle, using variously primary fetal or conditionally im mortalized cells as the sources of transplant material, allow us to conclude that the MHP36 cell line is not only multipotential (i.e., capable of giving rise to the range of mature cellular phenotypes that make up the central nervous system), but also "multifunctional" (i.e., capable of restoring function in a diverse range of types of brain damage with a corresponding range of func tional deficits). Clearly, there is considerable clinical po tential in cell lines that combine in this way conditional immortality, migratory capacity, multipotentiality, and multifunctionality. We have, therefore, recently em barked upon a program of research into the possibility of creating human cell lines with these same properties to take to the clinic.
